Nasal spray is being recalled over microbial failure. The U.S. Food and Drug Administration shared information about the recall affecting NeilMed Pharmaceuticals’ NasoGel Spray, last week. Here ...

A nasal rinse is a common practice to clear nasal passages, especially during cold, flu, and allergy seasons. It helps remove mucus, debris, and allergens that build in the nose. “A saltwater rinse is ...

The pea-size spot near the tip of his nose seemed so innocuous Ben Murray thought it might have been numb for a while and he simply hadn’t noticed. In March 2020, Murray, a videographer and ...

Bhad Bhabie/Instagram Bhad Bhabie revealed she got a nose job amid her cancer treatment. On Tuesday, Jan. 21, the rapper, 21, shared the news via Instagram Stories, per reposts on X. The star ...

Bhad Bhabie got candid about getting a nose job. Bhabie, 21, took to Instagram on Tuesday, January 21, to reveal she went under the knife. “Nose jobs are not for the weak!!” she wrote in a ...

Odours are first captured by special olfactory nerve cells inside your nose. These cells extend upwards from the roof of your nose towards the smell-processing centre of your brain, called the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

But hidden at your pharmacy among the potpourri of cough drops and cold remedies, you can find a low-risk treatment that actually may help: nasal irrigation devices. Several small studies suggest ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...